Life sciences
Our specialist life sciences team understand the complex nature of the sector.
Time-to-market and funding are the crucial factors driving innovation and successful new pharmaceutical product launches, which in turn, require laboratories, vivaria, pilot plants and manufacturing facilities. Avison Young’s specialists understand the pharmaceutical product life cycle as well as the technical complexities that can create significant budgetary and scheduling risk.
We’ve successfully addressed the risks that surround real estate decision making throughout all phases of the product life cycle and across all technical aspects of planning, designing, engineering and constructing any type of life science space.

Life Sciences key contacts

News and updates
-
Avison Young strengthens leadership with new Managing Director of National Offices06 March 2025
-
Avison Young appoints new head of Public and Health Sector03 March 2025
-
Avison Young strengthens leadership with new head of Valuation in London24 February 2025
-
Avison Young appointed by University of Kent as strategic advisor on 97 hectare site primed for 2,000 new homes24 February 2025